vs
Corebridge Financial, Inc.（CRBG）与Stryker Corporation（SYK）财务数据对比。点击上方公司名可切换其他公司
Stryker Corporation的季度营收约是Corebridge Financial, Inc.的1.1倍（$7.2B vs $6.7B），Corebridge Financial, Inc.净利率更高（12.1% vs 11.8%，领先0.3%），Stryker Corporation同比增速更快（11.4% vs 1.7%），过去两年Stryker Corporation的营收复合增速更高（16.9% vs 7.4%）
Corebridge Financial, Inc.是美国知名金融服务提供商，下设个人退休、人寿保险、退休服务、机构市场四大核心业务板块，可为客户提供年金、寿险产品、退休规划、财富管理等综合金融服务，满足不同群体的多元财务需求。
斯特赖克是一款八轮装甲战车，衍生自加拿大LAV III步兵战车，而后者源自瑞士莫瓦格食人鱼系列装甲车。该型战车由加拿大通用动力陆地系统公司为美国陆军生产，制造工厂位于安大略省伦敦市。它默认采用8×4四轮驱动，可切换为8×8全轮驱动模式。
CRBG vs SYK — 直观对比
营收规模更大
SYK
是对方的1.1倍
$6.7B
营收增速更快
SYK
高出9.7%
1.7%
净利率更高
CRBG
高出0.3%
11.8%
两年增速更快
SYK
近两年复合增速
7.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.7B | $7.2B |
| 净利润 | $814.0M | $849.0M |
| 毛利率 | — | 64.5% |
| 营业利润率 | 14.4% | 25.2% |
| 净利率 | 12.1% | 11.8% |
| 营收同比 | 1.7% | 11.4% |
| 净利润同比 | -62.5% | 55.5% |
| 每股收益（稀释后） | $1.44 | $2.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRBGSYK
| Q4 25 | $6.7B | $7.2B | ||
| Q3 25 | $5.4B | $6.1B | ||
| Q2 25 | $2.7B | $6.0B | ||
| Q1 25 | $3.6B | $5.9B | ||
| Q4 24 | $6.6B | $6.4B | ||
| Q3 24 | $2.6B | $5.5B | ||
| Q2 24 | $3.7B | $5.4B | ||
| Q1 24 | $5.8B | $5.2B |
净利润CRBGSYK
| Q4 25 | $814.0M | $849.0M | ||
| Q3 25 | $144.0M | $859.0M | ||
| Q2 25 | $-660.0M | $884.0M | ||
| Q1 25 | $-664.0M | $654.0M | ||
| Q4 24 | $2.2B | $546.0M | ||
| Q3 24 | $-1.2B | $834.0M | ||
| Q2 24 | $365.0M | $825.0M | ||
| Q1 24 | $878.0M | $788.0M |
毛利率CRBGSYK
| Q4 25 | — | 64.5% | ||
| Q3 25 | — | 63.6% | ||
| Q2 25 | — | 63.8% | ||
| Q1 25 | — | 63.8% | ||
| Q4 24 | — | 64.9% | ||
| Q3 24 | — | 64.0% | ||
| Q2 24 | — | 63.0% | ||
| Q1 24 | — | 63.6% |
营业利润率CRBGSYK
| Q4 25 | 14.4% | 25.2% | ||
| Q3 25 | -0.8% | 18.7% | ||
| Q2 25 | -22.2% | 18.5% | ||
| Q1 25 | -24.0% | 14.3% | ||
| Q4 24 | 44.2% | 9.0% | ||
| Q3 24 | -60.9% | 19.7% | ||
| Q2 24 | 12.3% | 19.4% | ||
| Q1 24 | 17.4% | 18.5% |
净利率CRBGSYK
| Q4 25 | 12.1% | 11.8% | ||
| Q3 25 | 2.7% | 14.2% | ||
| Q2 25 | -24.1% | 14.7% | ||
| Q1 25 | -18.5% | 11.1% | ||
| Q4 24 | 32.8% | 8.5% | ||
| Q3 24 | -45.3% | 15.2% | ||
| Q2 24 | 9.8% | 15.2% | ||
| Q1 24 | 15.0% | 15.0% |
每股收益（稀释后）CRBGSYK
| Q4 25 | $1.44 | $2.20 | ||
| Q3 25 | $0.27 | $2.22 | ||
| Q2 25 | $-1.20 | $2.29 | ||
| Q1 25 | $-1.19 | $1.69 | ||
| Q4 24 | $3.74 | $1.41 | ||
| Q3 24 | $-2.02 | $2.16 | ||
| Q2 24 | $0.59 | $2.14 | ||
| Q1 24 | $1.41 | $2.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $4.0B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $13.2B | $22.4B |
| 总资产 | $413.5B | $47.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CRBGSYK
| Q4 25 | — | $4.0B | ||
| Q3 25 | — | $3.3B | ||
| Q2 25 | — | $2.4B | ||
| Q1 25 | — | $2.3B | ||
| Q4 24 | — | $3.7B | ||
| Q3 24 | — | $3.9B | ||
| Q2 24 | — | $1.9B | ||
| Q1 24 | — | $2.3B |
股东权益CRBGSYK
| Q4 25 | $13.2B | $22.4B | ||
| Q3 25 | $13.5B | $21.8B | ||
| Q2 25 | $12.3B | $21.2B | ||
| Q1 25 | $12.0B | $20.9B | ||
| Q4 24 | $11.5B | $20.6B | ||
| Q3 24 | $13.6B | $20.1B | ||
| Q2 24 | $11.0B | $19.8B | ||
| Q1 24 | $11.6B | $19.2B |
总资产CRBGSYK
| Q4 25 | $413.5B | $47.8B | ||
| Q3 25 | $411.3B | $47.1B | ||
| Q2 25 | $399.2B | $46.3B | ||
| Q1 25 | $390.0B | $46.0B | ||
| Q4 24 | $389.4B | $43.0B | ||
| Q3 24 | $399.4B | $43.8B | ||
| Q2 24 | $382.5B | $39.1B | ||
| Q1 24 | $385.6B | $39.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.9B | $2.1B |
| 自由现金流经营现金流 - 资本支出 | — | $1.9B |
| 自由现金流率自由现金流/营收 | — | 26.1% |
| 资本支出强度资本支出/营收 | — | 3.7% |
| 现金转化率经营现金流/净利润 | 2.31× | 2.52× |
| 过去12个月自由现金流最近4个季度 | — | $4.3B |
8季度趋势，按日历期对齐
经营现金流CRBGSYK
| Q4 25 | $1.9B | $2.1B | ||
| Q3 25 | $24.0M | $1.5B | ||
| Q2 25 | $-259.0M | $1.1B | ||
| Q1 25 | $375.0M | $250.0M | ||
| Q4 24 | $1.5B | $1.9B | ||
| Q3 24 | $83.0M | $1.5B | ||
| Q2 24 | $-9.0M | $633.0M | ||
| Q1 24 | $598.0M | $204.0M |
自由现金流CRBGSYK
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $928.0M | ||
| Q1 25 | — | $127.0M | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $481.0M | ||
| Q1 24 | — | $37.0M |
自由现金流率CRBGSYK
| Q4 25 | — | 26.1% | ||
| Q3 25 | — | 22.3% | ||
| Q2 25 | — | 15.4% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 25.9% | ||
| Q3 24 | — | 23.7% | ||
| Q2 24 | — | 8.9% | ||
| Q1 24 | — | 0.7% |
资本支出强度CRBGSYK
| Q4 25 | — | 3.7% | ||
| Q3 25 | — | 3.1% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 4.1% | ||
| Q3 24 | — | 3.1% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | 3.2% |
现金转化率CRBGSYK
| Q4 25 | 2.31× | 2.52× | ||
| Q3 25 | 0.17× | 1.79× | ||
| Q2 25 | — | 1.26× | ||
| Q1 25 | — | 0.38× | ||
| Q4 24 | 0.68× | 3.54× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | -0.02× | 0.77× | ||
| Q1 24 | 0.68× | 0.26× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRBG
| Institutional Markets Segment | $2.9B | 43% |
| Life Insurance Operating Segment | $1.1B | 16% |
| Individual Retirement Segment | $1.0B | 16% |
| Other | $1.0B | 15% |
| Group Retirement Segment | $667.0M | 10% |
SYK
| Medical | $1.3B | 18% |
| Endoscopy | $1.1B | 16% |
| Traumaand Extremities | $1.1B | 15% |
| Instruments | $925.0M | 13% |
| Knees | $749.0M | 10% |
| Neuro Cranial | $669.0M | 9% |
| Neurovascular | $539.0M | 8% |
| Hips | $499.0M | 7% |
| Other Orthopaedics | $267.0M | 4% |
| Spine | $8.0M | 0% |
